Vaxart Inc (VXRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2002 | 12-2001 | 06-2001 | 12-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,474 | 104,682 | 0 | 4,359 | 0 |
| Depreciation Amortization | 11,009 | 9,491 | 5,300 | 9,838 | 5,030 |
| Income taxes - deferred | 131 | 4,258 | 0 | N/A | 0 |
| Accounts receivable | -1,037 | 1,648 | 0 | -4,676 | 0 |
| Other Working Capital | -3,902 | 4,428 | 4,640 | -3,295 | -3,650 |
| Other Operating Activity | 3,245 | -100,456 | 3,030 | 3,585 | 360 |
| Operating Cash Flow | $10,920 | $24,051 | $12,970 | $9,811 | $1,740 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,021 | 139,130 | -8,400 | -18,983 | -9,660 |
| Purchase Sale Intangibles | -6,136 | -3,387 | 0 | -1,809 | 0 |
| Other Investing Activity | -6,136 | -3,387 | -190 | -1,809 | 0 |
| Investing Cash Flow | $-12,157 | $135,743 | $-8,590 | $-20,792 | $-9,660 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -78,500 | -31,035 | 0 | -1,463 | 0 |
| Common Stock Issued | 1,199 | 1,856 | 0 | 13,192 | 0 |
| Common Stock Repurchased | -917 | -977 | 0 | N/A | 0 |
| Other Financing Activity | 0 | 0 | -130 | 0 | 3,000 |
| Financing Cash Flow | $-78,218 | $-30,156 | $-130 | $11,729 | $3,000 |
| Beginning Cash Position | 131,192 | 1,554 | 0 | 806 | 0 |
| End Cash Position | 51,737 | 131,192 | 0 | 1,554 | 0 |
| Net Cash Flow | $-79,455 | $129,638 | $4,250 | $748 | $-4,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,920 | 24,051 | 12,970 | 9,811 | 1,740 |
| Capital Expenditure | -6,021 | -13,052 | 0 | -18,983 | 0 |
| Free Cash Flow | 4,899 | 10,999 | 12,970 | -9,172 | 1,740 |